207
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Development and Validation of the Simplified Chinese Version of EORTC QLQ-HCC18 for Patients with Hepatocellular Carcinoma

, , , , , & show all
Pages 340-346 | Received 25 Jun 2014, Accepted 28 Mar 2015, Published online: 05 Jun 2015
 

Abstract

This study aimed to develop and validate the Simplified Chinese Version of the Quality of Life Questionnaire for Hepatocellular Carcinoma (the QLQ-HCC18). It was developed by the strict translation procedure of EORTC guidelines, and the psychometrics were evaluated on a sample of 114 patients. The internal consistency Cronbach's α were greater than 0.60 for all domains (exception of Jaundice 0.38), and all test–retest reliability coefficients were greater than 0.80. Four out of eight domains had statistically significant changes with effect size standardized response mean (SRM) ranging from 0.31 to 0.73. The Simplified Chinese version of QLQ-HCC18 demonstrates good validity, reliability, and responsiveness.

ACKNOWLEDGMENT

In carrying out this research project, we received substantial assistance from Prof. Neil Aaronson at EORTC, and many staff including Gaofeng Li, Gang Bai, Hongying Yang at the Yunnan Tumor Hospital, and Prof. Gary Lyman from Hutchinson Institute for Cancer Outcomes Research, and Fred Hutchinson Cancer Research Center. We sincerely appreciate their kind help.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.